US 12,310,914 B2
Method and system of mechanical nerve stimulation for pain relief
Meredith McGee, Cary, NC (US); Nathan Crosby, Cleveland, OH (US); John Chae, Strongsville, OH (US); and Joseph W. Boggs, Chapel Hill, NC (US)
Assigned to SPR THERAPEUTICS, INC., Cleveland, OH (US)
Filed by SPR Therapeutics, Inc., Cleveland, OH (US)
Filed on Nov. 6, 2023, as Appl. No. 18/502,131.
Application 18/502,131 is a continuation of application No. 18/084,629, filed on Dec. 20, 2022, granted, now 11,806,300.
Application 18/084,629 is a continuation of application No. 15/790,564, filed on Oct. 23, 2017, granted, now 11,540,973, issued on Jan. 3, 2023.
Claims priority of provisional application 62/411,068, filed on Oct. 21, 2016.
Prior Publication US 2024/0065931 A1, Feb. 29, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61H 23/00 (2006.01); A61H 39/08 (2006.01)
CPC A61H 23/006 (2013.01) [A61H 23/004 (2013.01); A61H 39/08 (2013.01); A61H 2203/03 (2013.01)] 13 Claims
OG exemplary drawing
 
1. A method comprising:
percutaneously implanting a flexible, open-coiled helical lead in a tissue of a body;
permitting fibrotic ingrowth or encapsulation of the flexible, open-coiled helical lead to the body to permit connection of the flexible, open-coiled helical lead to a neural receptor;
after fibrotic ingrowth or encapsulation, allowing transference of energy from movement of the flexible, open-coiled helical lead relative to the tissue without electrical stimulation; and
causing mechanical generation of an action potential in at least one of Type Ia and Type Ib target afferent nerve fibers while avoiding generation of action potentials in non-target Type III and IV nerve fibers, wherein the at least one of Type Ia and Type Ib target afferent nerve fibers are located outside a central nervous system of the body.